tiprankstipranks
Puma Biotechnology (PBYI)
NASDAQ:PBYI
US Market
PBYI
Puma Biotechnology
RESEARCH TOOLSreports

Puma Biotechnology (PBYI) Ratios

670 Followers

Puma Biotechnology Ratios

PBYI's free cash flow for Q4 2025 was $0.69. For the 2025 fiscal year, PBYI's free cash flow was decreased by $ and operating cash flow was $0.24. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.00 2.00 1.54 1.57 1.73
Quick Ratio
 2.00 1.93 1.45 1.50 1.67
Cash Ratio
 0.36 0.36 0.72 0.85 0.98
Solvency Ratio
 0.56 0.49 0.34 0.19 0.05
Operating Cash Flow Ratio
 0.51 0.51 0.40 0.27 -0.20
Short-Term Operating Cash Flow Coverage
 1.86 1.75 0.86 0.79 0.00
Net Current Asset Value
$ 76.72M$ 76.72M$ 26.45M$ -20.90M$ -66.17M
Leverage Ratios
Debt-to-Assets Ratio
 0.13 0.13 0.35 0.48 0.51
Debt-to-Equity Ratio
 0.22 0.22 0.80 2.09 5.29
Debt-to-Capital Ratio
 0.18 0.18 0.45 0.68 0.84
Long-Term Debt-to-Capital Ratio
 0.00 0.03 0.19 0.55 0.82
Financial Leverage Ratio
 1.66 1.66 2.32 4.31 10.28
Debt Service Coverage Ratio
 1.87 1.60 0.94 0.98 1.85
Interest Coverage Ratio
 5.65 5.63 2.49 2.45 2.05
Debt to Market Cap
 0.06 0.10 0.45 0.49 0.52
Interest Debt Per Share
 0.70 0.70 1.78 2.65 2.82
Net Debt to EBITDA
 -0.02 -0.02 0.10 0.57 1.74
Profitability Margins
Gross Profit Margin
74.51%74.53%72.06%73.40%75.84%
EBIT Margin
18.55%18.57%15.86%15.28%5.28%
EBITDA Margin
25.84%23.36%20.86%20.17%9.60%
Operating Profit Margin
16.33%16.33%13.44%13.85%10.40%
Pretax Profit Margin
15.66%15.67%10.46%9.62%0.20%
Net Profit Margin
13.60%13.62%13.14%9.16%<0.01%
Continuous Operations Profit Margin
13.62%13.62%13.14%9.16%<0.01%
Net Income Per EBT
86.86%86.95%125.63%95.22%0.44%
EBT Per EBIT
95.93%95.93%77.83%69.47%1.93%
Return on Assets (ROA)
14.37%14.38%14.19%9.37%<0.01%
Return on Equity (ROE)
27.78%23.87%32.87%40.40%<0.01%
Return on Capital Employed (ROCE)
27.61%27.62%26.42%24.89%16.41%
Return on Invested Capital (ROIC)
20.41%20.41%18.42%18.29%0.07%
Return on Tangible Assets
17.77%17.79%18.67%12.73%<0.01%
Earnings Yield
8.22%10.46%20.41%10.58%<0.01%
Efficiency Ratios
Receivables Turnover
 4.26 4.26 7.20 4.86 5.39
Payables Turnover
 11.52 11.50 11.69 9.10 8.55
Inventory Turnover
 0.00 10.55 7.38 8.85 12.17
Fixed Asset Turnover
 0.00 41.07 45.24 27.25 18.23
Asset Turnover
 1.06 1.06 1.08 1.02 1.03
Working Capital Turnover Ratio
 3.21 3.43 4.25 4.15 5.23
Cash Conversion Cycle
 54.04 88.63 68.92 76.22 54.98
Days of Sales Outstanding
 85.74 85.75 50.70 75.11 67.66
Days of Inventory Outstanding
 0.00 34.61 49.44 41.23 29.99
Days of Payables Outstanding
 31.69 31.73 31.22 40.11 42.67
Operating Cycle
 85.74 120.37 100.14 116.34 97.65
Cash Flow Ratios
Operating Cash Flow Per Share
 0.83 0.84 0.80 0.57 -0.35
Free Cash Flow Per Share
 0.83 0.83 0.80 0.30 -0.51
CapEx Per Share
 <0.01 <0.01 <0.01 0.27 0.16
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 0.53 1.44
Dividend Paid and CapEx Coverage Ratio
 588.76 588.76 694.96 2.14 -2.26
Capital Expenditure Coverage Ratio
 588.76 588.76 694.96 2.14 -2.26
Operating Cash Flow Coverage Ratio
 1.46 1.46 0.53 0.24 -0.14
Operating Cash Flow to Sales Ratio
 0.18 0.18 0.17 0.11 -0.07
Free Cash Flow Yield
10.92%14.02%26.19%7.04%-12.08%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 11.29 9.56 4.90 9.45 94.49K
Price-to-Sales (P/S) Ratio
 1.55 1.30 0.64 0.87 0.83
Price-to-Book (P/B) Ratio
 2.69 2.28 1.61 3.82 8.75
Price-to-Free Cash Flow (P/FCF) Ratio
 8.50 7.13 3.82 14.20 -8.28
Price-to-Operating Cash Flow Ratio
 8.39 7.12 3.81 7.56 -11.94
Price-to-Earnings Growth (PEG) Ratio
 -0.71 0.00 0.14 <0.01 -918.83
Price-to-Fair Value
 2.69 2.28 1.61 3.82 8.75
Enterprise Value Multiple
 5.99 5.56 3.19 4.86 10.37
Enterprise Value
 381.03M 296.48M 153.24M 231.00M 227.05M
EV to EBITDA
 6.46 5.56 3.19 4.86 10.37
EV to Sales
 1.67 1.30 0.66 0.98 1.00
EV to Free Cash Flow
 9.13 7.10 3.94 16.08 -9.95
EV to Operating Cash Flow
 9.12 7.09 3.94 8.55 -14.35
Tangible Book Value Per Share
 1.77 1.78 0.84 -0.16 -1.10
Shareholders’ Equity Per Share
 2.59 2.61 1.89 1.13 0.48
Tax and Other Ratios
Effective Tax Rate
 0.13 0.13 -0.26 0.05 1.00
Revenue Per Share
 4.54 4.57 4.74 5.00 5.10
Net Income Per Share
 0.62 0.62 0.62 0.46 <0.01
Tax Burden
 0.87 0.87 1.26 0.95 <0.01
Interest Burden
 0.84 0.84 0.66 0.63 0.04
Research & Development to Revenue
 0.27 0.27 0.24 0.21 0.23
SG&A to Revenue
 0.31 0.31 0.35 0.38 0.39
Stock-Based Compensation to Revenue
 0.05 0.03 0.04 0.04 0.05
Income Quality
 1.42 1.34 1.29 1.25 -7.91K
Currency in USD